Abstract LB-298: The novel triple PI3K-CDK4/6-BRD4 inhibitor SRX3177 harnesses synthetic lethality relationships to orthogonally disrupt cancer cell signaling
2009 ◽
2019 ◽
Vol 120
(8)
◽
pp. 12224-12246
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 134
(7)
◽
pp. 1517-1528
◽